HTSUY
Price
$6.79
Change
+$0.05 (+0.74%)
Updated
Jul 8 closing price
Capitalization
1.96B
ORXOY
Price
$1.99
Change
+$0.51 (+34.46%)
Updated
Jul 8 closing price
Capitalization
57.75M
Interact to see
Advertisement

HTSUY vs ORXOY

Header iconHTSUY vs ORXOY Comparison
Open Charts HTSUY vs ORXOYBanner chart's image
Hisamitsu Pharmaceutical
Price$6.79
Change+$0.05 (+0.74%)
Volume$100
Capitalization1.96B
Orexo AB
Price$1.99
Change+$0.51 (+34.46%)
Volume$1.16K
Capitalization57.75M
HTSUY vs ORXOY Comparison Chart in %
Loading...
HTSUY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORXOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HTSUY vs. ORXOY commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HTSUY is a Hold and ORXOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (HTSUY: $6.80 vs. ORXOY: $1.99)
Brand notoriety: HTSUY and ORXOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HTSUY: 22% vs. ORXOY: 120%
Market capitalization -- HTSUY: $1.96B vs. ORXOY: $57.75M
HTSUY [@Pharmaceuticals: Other] is valued at $1.96B. ORXOY’s [@Pharmaceuticals: Other] market capitalization is $57.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HTSUY’s FA Score shows that 1 FA rating(s) are green whileORXOY’s FA Score has 0 green FA rating(s).

  • HTSUY’s FA Score: 1 green, 4 red.
  • ORXOY’s FA Score: 0 green, 5 red.
According to our system of comparison, both HTSUY and ORXOY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HTSUY’s TA Score shows that 0 TA indicator(s) are bullish while ORXOY’s TA Score has 1 bullish TA indicator(s).

  • HTSUY’s TA Score: 0 bullish, 1 bearish.
  • ORXOY’s TA Score: 1 bullish, 2 bearish.
According to our system of comparison, HTSUY is a better buy in the short-term than ORXOY.

Price Growth

HTSUY (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while ORXOY (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.92%. For the same industry, the average monthly price growth was +5.95%, and the average quarterly price growth was +72.47%.

Reported Earning Dates

ORXOY is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.92% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HTSUY($1.96B) has a higher market cap than ORXOY($57.7M). ORXOY YTD gains are higher at: 5.570 vs. HTSUY (-4.093). HTSUY has higher annual earnings (EBITDA): 19.8B vs. ORXOY (-79.4M). HTSUY has more cash in the bank: 124B vs. ORXOY (251M). ORXOY has less debt than HTSUY: ORXOY (517M) vs HTSUY (1.17B). HTSUY has higher revenues than ORXOY: HTSUY (139B) vs ORXOY (634M).
HTSUYORXOYHTSUY / ORXOY
Capitalization1.96B57.7M3,397%
EBITDA19.8B-79.4M-24,937%
Gain YTD-4.0935.570-73%
P/E Ratio24.92N/A-
Revenue139B634M21,924%
Total Cash124B251M49,402%
Total Debt1.17B517M226%
FUNDAMENTALS RATINGS
ORXOY: Fundamental Ratings
ORXOY
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HTSUYORXOY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
10%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
15%
Bullish Trend 2 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
16%
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HTSUY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORXOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVSCX15.730.01
+0.06%
Calamos Market Neutral Income C
MKDCX26.42N/A
N/A
BlackRock Emerging Mkts K
EDIRX11.25N/A
N/A
Eaton Vance Global Income Builder R
COVAX12.99N/A
N/A
Columbia Small Cap Value II A
BGVCX32.47N/A
N/A
Brandes Global Equity C

HTSUY and

Correlation & Price change

A.I.dvisor tells us that HTSUY and MSTH have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUY and MSTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUY
1D Price
Change %
HTSUY100%
N/A
MSTH - HTSUY
12%
Poorly correlated
N/A
TKNO - HTSUY
4%
Poorly correlated
+1.16%
BFRI - HTSUY
4%
Poorly correlated
+1.77%
ORXOY - HTSUY
0%
Poorly correlated
N/A
HNSPF - HTSUY
0%
Poorly correlated
N/A
More

ORXOY and

Correlation & Price change

A.I.dvisor tells us that ORXOY and APNHF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORXOY and APNHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORXOY
1D Price
Change %
ORXOY100%
N/A
APNHF - ORXOY
28%
Poorly correlated
N/A
TKNO - ORXOY
8%
Poorly correlated
+1.16%
SEHCF - ORXOY
5%
Poorly correlated
N/A
GLASF - ORXOY
4%
Poorly correlated
+5.58%
HTSUY - ORXOY
0%
Poorly correlated
N/A
More